Effect of Oral Fructose Load on Serum Uric Acid and Lipids in Kidney Transplant Recipients Treated With Cyclosporine or Tacrolimus

Transplantation Proceedings

Volumn 41, Issue 1, 2009, Pages 188-191

  Zawiasa, A ^a   Szklarek Kubicka, M ^a   Fijalkowska Morawska J ^a   Nowak, D ^a   Rysz, J ^a   Mamelka B ^a   Nowicki, M ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; CYCLOSPORIN A; FRUCTOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; TRIACYLGLYCEROL; URIC ACID;

ADULT; ANALYTIC METHOD; ARTICLE; BLOOD PRESSURE MEASUREMENT; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MALE; ORAL FRUCTOSE TOLERANCE TEST; PRIORITY JOURNAL; RECIPIENT; SIDE EFFECT; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

ADULT; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CYCLOSPORINE; DRUG TOLERANCE; FRUCTOSE; GLOMERULAR FILTRATION RATE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIPIDS; MIDDLE AGED; MYCOPHENOLIC ACID; TACROLIMUS; TRIGLYCERIDES; URIC ACID;

EID: 60649092160     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.10.038     Document Type: Article

References (26)

1. Clive D.M. Renal transplant-associated hyperuricemia and gout. J Am Soc Nephrol 11 (2000) 974
2. Lin H.-Y., Rocher L.L., McQuillan M.A., et al. Cyclosporine-induced hyperuricemia and gout. N Engl J Med 321 (1989) 287
3. Kanbay M., Akcay A., Huddam B., et al. Influence of cyclosporine and tacrolimus on serum uric acid levels in stable kidney transplant recipients. Transplant Proc 37 (2005) 3119
4. Armstrong K., Johnson D., Campbell S., et al. Does uric acid have a pathogenetic role in graft dysfuction and hypertension in renal transplant recipients?. Transplantation 80 (2005) 1565
5. Kamper A.L., and Nielsen A.H. Uricosuric effect of losartan in patients with renal transplants. Transplantation 72 (2001) 671
6. Nakagawa T., Tuttle K.R., Short R.A., et al. Hypothesis: fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome. Nat Clin Prac Nephrol 1 (2005) 80
7. Bantle J.P., Raatz S.K., Thomas W., et al. Effects of dietary fructose on plasma lipids in healthy subjects. Am J Clin Nutr 72 (2000) 1128
8. Elliott S.S., Keim N.H., Stern J.S., et al. Fructose, weight gain and the insulin resistance syndrome. Am J Clin Nutr 77 (2002) 911
9. Choi H.K., Mount D.B., and Reginato A.M. Pathogenesis of gout. Ann Intern Med 143 (2005) 499
10. Khosla U.M., Zharikov S., Finch J.L., et al. Hyperuricemia induces endothelial dysfunction. Kidney Int 67 (2005) 1739
11. Gerhardt U., Grosse Hutmann M., and Hohage H. Influence of hyperglycemia and hyperuricemia on long-term transplant survival in kidney transplant recipients. Clin Transplant 13 (1999) 375
12. Sanchez-Lozada L.G., Tapia E., Jimenez A., et al. Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats. Am J Physiol Renal Physiol 292 (2007) 423
13. Conen D., Wietlisbach V., Bovet P., et al. Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC Public Health 4 (2004) 1
14. Johnson R.J., and Rideout B.A. Uric acid and diet: insights into the epidemic of cardiovascular disease. N Engl J Med 350 (2004) 1071
15. Ruilope L.M., and Garcia-Puig J. Hyperuricemia and renal function. Curr Hypertens Rep 3 (2001) 197
16. Heinig M., and Johnson R.J. Role of uric acid in hypertension, renal disease and metabolic syndrome. Cleve Clin J Med 73 (2006) 1059
17. Johnson R.J., Segal M.S., Sautin Y., et al. Potential role of sugar (fructose) in the epidemic of hypertension, obesity, metabolic syndrome and cardiovascular disease. Am J Clin Nutr 86 (2007) 899
18. Pilmore H.L., Faire B., and Dittmer I. Tacrolimus for the treatment of gout in renal transplantation: two case reports and review of the literature. Transplantation 72 (2002) 1703
19. Ejaz A.A., Mu W., Kang D.H., et al. Could uric acid have a role in acute renal failure?. Clin J Am Soc Nephrol 2 (2007) 16
20. Mayes P.A. Intermediary metabolism of fructose. Am J Clin Nutr 58 suppl (1993) 754S
21. Le K.-A., Faeh D., Stettler R., et al. A 4-wk high-fructose diet alters lipid metabolism without affecting insulin sensitivity or ectopic lipids in healthy humans. Am J Clin Nutr 84 (2006) 1374
22. Hohage H., Hillebrandt U., Welling U., et al. Cyclosporine and tacrolimus: influence on cardiovascular risk factors. Transplant Proc 37 (2005) 1036
23. Perlstein T.S., Gumieniak O., Williams G.H., et al. Uric acid and the development of hypertension: the normative aging study. Hypertension 48 (2006) 1031
24. Morales J.M. Influence of the new immunosuppressive combinations on arterial hypertension after renal transplantation. Kidney Int Suppl 82 (2002) S81
25. Morales J.M., Andres A., Rengel M., et al. Influence of cyclosporin, tacrolimus and rapamycin on renal function and arterial hypertension after renal transplantation. Nephrol Dial Transplant 16 suppl 1 (2001) 121
26. Margreiter R. Efficacy and safety of tacrolimus compared with cyclosporin microemulsion in renal transplantation: a randomised multicentre study. Lancet 9308 (2002) 741